Epinephrine is classified as a vasopressor, but the full picture is more interesting than a simple yes. At higher doses, it powerfully raises blood pressure by constricting blood vessels through alpha-adrenergic receptors. At lower doses, it can actually drop blood pressure by relaxing blood vessels through beta-adrenergic receptors. This dose-dependent split personality makes epinephrine one of the more versatile and misunderstood drugs in emergency and critical care medicine.
What Makes a Drug a “Pressor”
A vasopressor is any substance that raises blood pressure, usually by tightening blood vessels. Epinephrine qualifies, but calling it simply a pressor understates what it does. Unlike a pure vasoconstrictor such as phenylephrine, epinephrine acts on multiple receptor types simultaneously. It stimulates alpha-1 receptors on blood vessels, which causes constriction and raises arterial pressure. It also stimulates beta-1 receptors in the heart, which increases heart rate and the force of each heartbeat. And it stimulates beta-2 receptors in certain blood vessels, particularly those supplying skeletal muscle, which actually causes those vessels to relax and widen.
The net effect on blood pressure depends on which receptor effects dominate, and that changes with the dose. Epinephrine’s alpha-1 vasoconstricting effects tend to require higher concentrations to fully kick in, while its beta-2 vasodilating effects show up at lower concentrations. This is why clinicians sometimes describe epinephrine as having a “biphasic” effect on blood pressure.
The Low-Dose Surprise
Most people assume epinephrine always pushes blood pressure up. In reality, at low infusion rates, it can push blood pressure down. A study in anesthetized pigs demonstrated this clearly: at low doses, adrenaline decreased systolic blood pressure from about 118 to 106 mmHg and diastolic pressure from about 86 to 71 mmHg. At high doses, both systolic and diastolic pressures climbed. When the researchers blocked the beta receptors beforehand, the blood pressure drop at low doses disappeared, confirming that beta-adrenergic vasodilation was responsible for the decrease. And when they blocked the alpha receptors, the blood pressure rise at high doses disappeared, confirming that alpha-adrenergic vasoconstriction drove the increase.1PubMed Central. Low-Dose Adrenaline Reduces Blood Pressure Acutely in Anesthetized Pigs Through a β2-Adrenergic Pathway
Work in newborn piglets showed the same pattern from a slightly different angle: at three lower dose levels, both systemic and pulmonary vascular resistance fell, meaning blood vessels throughout the body were relaxing. As the dose climbed further, systemic vasoconstriction began to dominate, and the systemic vascular resistance rose more steeply than pulmonary resistance.2Pediatric Research. The Circulatory Effects of Infusion in the Anesthetized Piglet In practical terms, this means a clinician titrating an epinephrine drip could see a dip in blood pressure before the expected rise, particularly when starting at very low rates.
How Epinephrine Raises Blood Pressure at Clinical Doses
At the doses used during emergencies, epinephrine raises blood pressure through two simultaneous mechanisms. First, it constricts peripheral blood vessels through alpha-1 receptor activation, which increases the resistance that the heart pumps against and pushes arterial pressure upward. Second, it stimulates the heart through beta-1 receptors, increasing both the rate and the contractile force, which boosts the volume of blood ejected per minute. The combination of tighter vessels and a harder-pumping heart produces rapid and dramatic increases in blood pressure.
During cardiac arrest, the pressor action is particularly important because it helps maintain coronary perfusion, the flow of blood through the heart’s own arteries. Without adequate coronary perfusion pressure during CPR, the heart muscle receives too little oxygen to resume beating. Epinephrine raises arterial blood pressure and coronary perfusion during resuscitation primarily through its alpha-1 effects.3PubMed. Epinephrine for cardiac arrest One study of patients in prolonged cardiac arrest found that a standard dose of epinephrine raised coronary perfusion pressure by only about 3.7 mmHg on average, a change that was not statistically significant. A high dose, however, raised it by about 11.3 mmHg and was more likely to push coronary perfusion pressure above the critical threshold of 15 mmHg thought to be necessary for successful resuscitation.4PubMed. The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation
Epinephrine in Anaphylaxis
Anaphylaxis is probably the most familiar scenario where epinephrine’s pressor effects save lives. During a severe allergic reaction, blood vessels dilate massively and become leaky, causing blood pressure to plummet. Epinephrine counteracts this by constricting those dilated vessels, which props blood pressure back up, and by relaxing airway smooth muscle through beta-2 receptors, which reopens constricted airways. It is the first-line treatment worldwide for anaphylaxis.
Here is something that surprises many people: despite epinephrine autoinjectors being one of the most widely prescribed emergency medications, there has never been a randomized controlled trial proving their effectiveness in anaphylaxis in the community. A Cochrane review identified over 1,300 studies on the topic but found that none met the criteria for a proper randomized trial of autoinjectors in real-world anaphylaxis treatment.5PubMed Central. Adrenaline auto‐injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community The evidence for epinephrine in anaphylaxis comes from decades of clinical experience, animal studies, and observational data rather than randomized trials. The ethical obstacle is obvious: you cannot give someone experiencing a life-threatening allergic reaction a placebo injection.
How the injection is delivered matters for how quickly the pressor effect kicks in. Intramuscular injection into the thigh produces significantly higher peak blood levels of epinephrine than injection into the upper arm, whether given intramuscularly or subcutaneously.6PubMed. Epinephrine absorption in adults: intramuscular versus subcutaneous injection This is why autoinjectors are designed to be used in the outer thigh: the muscle there is large and well-supplied with blood, giving the fastest absorption and the most reliable pressor response.7PubMed Central. The pharmacokinetics of epinephrine/adrenaline autoinjectors
Epinephrine Compared to Norepinephrine
If you are wondering why hospitals sometimes use norepinephrine instead of epinephrine to raise blood pressure, the answer comes down to receptor selectivity and side effects. Both drugs activate alpha-1 receptors and raise blood pressure, but they differ in emphasis. Norepinephrine is a more potent vasoconstrictor, while epinephrine is a stronger stimulant of the heart’s pumping power. Norepinephrine also increases the volume of blood returning to the heart, which helps boost cardiac output by a different route.8JAMA Network Open. Epinephrine vs Norepinephrine as Initial Treatment in Children With Septic Shock
In septic shock, where dangerously low blood pressure is caused by widespread infection-driven vasodilation, the choice between the two has real consequences. A study comparing epinephrine alone to a combination of norepinephrine and dobutamine found no statistical difference in the headline blood pressure numbers. However, epinephrine caused a concerning metabolic picture: blood lactate levels nearly doubled within six hours, and measures of gut blood flow worsened significantly. These metabolic derangements were transient, resolving within 24 hours, but the norepinephrine-dobutamine combination produced a more stable metabolic profile from the start.9PubMed. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study
When researchers compared epinephrine, norepinephrine, and phenylephrine at equivalent pressor doses in septic animals, epinephrine stood out for increasing heart rate, the heart’s oxygen consumption, and the frequency of abnormal heart rhythms more than the other two.10Anesthesiology. Comparison of Equipressor Doses of Norepinephrine, Epinephrine, and Phenylephrine on Septic Myocardial Dysfunction This is a recurring theme with epinephrine: it raises blood pressure effectively, but it asks the heart to work harder and burn more fuel to do so. In pediatric septic shock specifically, the same JAMA Network Open paper noted that epinephrine has been linked to higher rates of metabolic and cardiac complications in adults, particularly abnormal heart rhythms, though those complications did not appear in the children studied.8JAMA Network Open. Epinephrine vs Norepinephrine as Initial Treatment in Children With Septic Shock
The Lactate Puzzle
One of epinephrine’s most confusing side effects is that it raises blood lactate levels, a lab value clinicians normally interpret as a sign that tissues are not getting enough oxygen. In shock, rising lactate typically signals that organs are in trouble. But when epinephrine is the cause of the lactate rise, the picture is muddier. Research has shown that epinephrine drives lactate production in muscle through beta-2 receptor stimulation, essentially revving up a metabolic pathway that produces lactate even when oxygen supply to the tissue is perfectly adequate.11PubMed. Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states
This matters because clinicians rely heavily on lactate trends to judge whether a patient in shock is getting better or worse. If epinephrine is the vasopressor being used, a rising lactate level might represent a drug side effect rather than clinical deterioration. Misreading that signal could lead to unnecessary dose escalation or panic. It is one of the practical reasons many intensive care units now prefer norepinephrine as a first-line pressor in septic shock: the lactate signal stays cleaner and easier to interpret.
Why Age Changes the Pressor Response
The blood-pressure-raising effect of epinephrine is not the same in a 25-year-old and a 70-year-old. A study comparing cardiovascular responses across age groups found that younger subjects had larger increases in stroke volume, ejection fraction, cardiac output, and systolic blood pressure after receiving adrenaline. They also had larger decreases in diastolic blood pressure, consistent with stronger beta-2-mediated vasodilation. Older subjects had a blunted version of both responses.12PubMed Central. Effects of age on cardiovascular responses to adrenaline in man
The upshot is that the net pressor effect of a given dose of epinephrine changes with age. Younger people get a bigger cardiac boost and more vasodilation in the periphery, while older adults get a more muted overall response. This has implications for dosing in emergencies: the same milligram dose may produce different hemodynamic profiles depending on the patient’s age, and clinicians factor this in when choosing vasopressor strategies for elderly patients in the ICU.
The Beta-Blocker Trap
One of the most dangerous drug interactions involving epinephrine’s pressor effects is the combination with beta-blockers. When someone is already on a beta-blocker, the beta-1 and beta-2 receptors are partially or fully blocked. If that person then receives epinephrine, the beta-mediated effects, like heart rate increase and vasodilation, are suppressed. But the alpha-mediated vasoconstriction is completely unopposed. The result is a dramatic and dangerous spike in blood pressure.
A case report described a patient on propranolol who received subcutaneous epinephrine in an emergency department and developed severe hypertension paired with profound bradycardia, a combination that can be immediately life-threatening.13Annals of Emergency Medicine. Propranolol-epinephrine interaction: severe hypertension and bradycardia Animal research confirmed the mechanism: when rats pretreated with the beta-blocker pindolol received epinephrine, they developed exaggerated alpha-driven vasoconstriction and, in some cases, pulmonary congestion or edema. Blocking the alpha receptors with phentolamine prevented these effects, confirming that the problem was unopposed alpha stimulation. A more selective beta-blocker (acebutolol) did not produce the same dramatic reaction.14PubMed. Interaction between beta blockers and epinephrine on hemodynamics of spontaneously hypertensive rats
This interaction is clinically significant because millions of people take beta-blockers for high blood pressure, heart failure, or anxiety. If one of those patients has an anaphylactic reaction, the standard epinephrine autoinjector may produce an abnormal hemodynamic response: the blood pressure may surge from alpha effects while the heart rate fails to increase as expected. Emergency physicians are trained to watch for this, and in some protocols, glucagon is used as an alternative or adjunct in anaphylaxis patients on beta-blockers because it increases heart rate and contractility through a pathway that does not depend on beta receptors at all.
Epinephrine as a Local Vasoconstrictor
There is an entirely different context in which epinephrine’s blood-vessel-tightening ability is used: as an additive to local anesthetic injections. When a dentist or surgeon injects a local anesthetic like lidocaine, adding a small amount of epinephrine causes the surrounding blood vessels to constrict. This slows the rate at which the anesthetic is absorbed into the bloodstream, keeping it concentrated at the injection site for longer and extending the duration of numbness. It also reduces bleeding in the surgical field. Recent pharmacokinetic work on continuous nerve-block techniques has reinforced that epinephrine reduces the systemic absorption of local anesthetics, which helps lower the risk of toxicity when large volumes of local anesthetic are infused over hours.15PubMed Central. Epinephrine, absorption, and local anaesthetic systemic toxicity: insights from continuous fascial block pharmacokinetic models
In this application, the pressor effect is entirely local. The tiny amount of epinephrine used (typically 1:100,000 or 1:200,000 concentration) produces vasoconstriction only in the tissue immediately around the injection. Systemic blood pressure changes from these concentrations are negligible in most patients, though people with uncontrolled hypertension or those on non-selective beta-blockers may occasionally notice a mild increase in heart rate or blood pressure from even small amounts.
Pulmonary Versus Systemic Effects
Epinephrine does not affect all vascular beds equally, and its behavior in the pulmonary (lung) circulation versus the systemic circulation has implications for patients with pulmonary hypertension. A pilot study in children with pulmonary hypertension found that epinephrine raised aortic (systemic) pressure, but its effect on the ratio of pulmonary-to-systemic vascular resistance was inconsistent: three of five patients saw the ratio decrease (favorable) while the other two did not. By comparison, vasopressin consistently lowered both the pulmonary-to-systemic resistance ratio and the ratio of pulmonary-to-aortic pressure.16Pediatric Critical Care Medicine. Hemodynamic Effects of Phenylephrine, Vasopressin, and Epinephrine in Children With Pulmonary Hypertension: A Pilot Study
For clinicians managing patients who need blood pressure support but also have elevated pressures in the lungs, this matters. An ideal pressor would raise systemic pressure without simultaneously raising pulmonary pressure, because the right side of the heart in pulmonary hypertension is already struggling against high resistance. Epinephrine’s unpredictable pulmonary effects make it a less-than-ideal choice in this specific population. The newborn piglet data described earlier showed the same asymmetry from a different angle: as the dose climbed, systemic vasoconstriction grew more steeply than pulmonary vasoconstriction.2Pediatric Research. The Circulatory Effects of Infusion in the Anesthetized Piglet That differential constriction is actually advantageous in some contexts, since it means epinephrine preferentially boosts systemic pressure more than pulmonary pressure at moderate-to-high doses, but the unpredictability across individual patients makes it less reliable than alternatives like vasopressin for pulmonary hypertension scenarios.
Receptor Binding and Why Structure Matters
At the molecular level, epinephrine’s dual personality as both a vasodilator and a vasoconstrictor traces back to how it physically docks into different receptor types. Structural studies have revealed that epinephrine adopts distinct three-dimensional shapes when binding to alpha versus beta receptors. In the alpha-2A receptor complex, for instance, the hydroxyl group on epinephrine’s beta-carbon points toward the extracellular surface, and its N-methyl group orients toward a specific amino acid in the receptor’s seventh transmembrane segment. In beta receptors, the molecule sits differently.17Experimental & Molecular Medicine. Distinct binding conformations of epinephrine with α- and β-adrenergic receptors
These conformational differences help explain why a single small molecule can trigger opposing effects in different tissues. The way epinephrine’s shape is “read” by each receptor type determines the downstream cascade that either relaxes or constricts a blood vessel. Future drug design could exploit these structural insights to create more selective agents that raise blood pressure without the cardiac overstimulation or metabolic complications that currently come as part of the package. For now, though, epinephrine remains the prototypical example of a drug whose pressor effects are both real and context-dependent, shaped by dose, receptor distribution, patient age, and what other medications are already on board.